Imidazoquinolines with immunomodulating properties

Details for Australian Patent Application No. 2008247165 (hide)

Owner AstraZeneca AB Dainippon Sumitomo Pharma Co. Ltd.

Inventors Bonnert, Roger Victor; Wada, Hiroki; Thom, Stephen; McInally, Thomas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008247165

PCT Pub. Number WO2008/135791

Priority 61/024,957 31.01.08 US; 60/916,586 08.05.07 US

Filing date 6 May 2008

Wipo publication date 13 November 2008

Acceptance publication date 3 November 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/135791 Priority application(s): WO2008/135791

3 November 2011 Application Accepted

  Published as AU-B-2008247165

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247169-Polymorphic forms of bosentan

2008247159-9-(pyrazol3 -yl) -9Hpurine-2 -amine and 3-(pyrazol-3-yl) -3H-imidazo [4,5-B]pyridin-5-amine derivatives and their use for the treatment of cancer